Clinical Trial Update: CD4 CAR+ ZFN-modified T Cells in HIV Therapy [Phase 1]

View source ↗

Summary

This entry notes a Phase 1 clinical trial evaluating CD4 CAR+ ZFN-modified T cells as a therapy for HIV, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CD4 CAR+ ZFN-modified T cells

Snippet

Sponsor: University of Pennsylvania | Conditions: Hiv | Phase 1 | Status: ACTIVE_NOT_RECRUITING